Debilitating Fibrosing Skin Disorders (Localised Scleroderma, Eosinophilic Fasciitis)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Debilitating Fibrosing Skin Disorders (Localised Scleroderma, Eosinophilic Fasciitis) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 2

NCT00936546

A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and…

This study will evaluate the safety and efficacy of the combination of rituximab and methotrexate to treat disabling fibrosing skin disorders.Rituximab will be…

Belgium3 participantsStarted 2009-06

Treatment: Rituximab